Innovative Cancer Test Predicts Treatment Needs a Decade in Advance
TL;DR Summary
The study introduces EVOFLUx, a cost-effective computational framework that uses DNA methylation patterns, specifically fluctuating CpGs, to infer the evolutionary history of cancers at clinical scale, revealing insights into tumor growth, subclonal architecture, and prognostic implications across lymphoid malignancies.
Topics:health#cancer-evolution#clonal-dynamics#dna-methylation#evoflux#health-and-medicine#lymphoid-neoplasms
- Fluctuating DNA methylation tracks cancer evolution at clinical scale Nature
- New cancer test can warn patients up to 10 years before treatment is needed ASU News
- New cancer test predicts, up to 10 years in advance, when treatment will be needed The Institute of Cancer Research
- Taming cancer evolution surprises Nature
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
81 min
vs 81 min read
Condensed
100%
16,198 → 39 words
Want the full story? Read the original article
Read on Nature